These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11400095)

  • 1. An experimental and theoretical study of the inhibition of Escherichia coli lac operon gene expression by antigene oligonucleotides.
    Cheng B; Fournier RL; Relue PA; Schisler J
    Biotechnol Bioeng; 2001 Aug; 74(3):220-9. PubMed ID: 11400095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of Escherichia coli lac operon gene expression by antigene oligonucleotides-mathematical modeling.
    Cheng B; Fournier RL; Relue PA
    Biotechnol Bioeng; 2000 Nov; 70(4):467-72. PubMed ID: 11005930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical model of the lac operon: inducer exclusion, catabolite repression, and diauxic growth on glucose and lactose.
    Wong P; Gladney S; Keasling JD
    Biotechnol Prog; 1997; 13(2):132-43. PubMed ID: 9104037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation.
    Shao Y; Wu Y; Chan CY; McDonough K; Ding Y
    Nucleic Acids Res; 2006; 34(19):5660-9. PubMed ID: 17038332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth rate regulation of lac operon expression in Escherichia coli is cyclic AMP dependent.
    Kuo JT; Chang YJ; Tseng CP
    FEBS Lett; 2003 Oct; 553(3):397-402. PubMed ID: 14572658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-benefit tradeoffs in engineered lac operons.
    Eames M; Kortemme T
    Science; 2012 May; 336(6083):911-5. PubMed ID: 22605776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor.
    Rubenstein M; Glick R; Lichtor T; Mirochnik Y; Chou P; Guinan P
    Med Oncol; 2001; 18(2):121-30. PubMed ID: 11778757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. opp-lac Operon fusions and transcriptional regulation of the Escherichia coli trp-linked oligopeptide permease.
    Andrews JC; Short SA
    J Bacteriol; 1986 Feb; 165(2):434-42. PubMed ID: 3080404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides.
    Fillion P; Desjardins A; Sayasith K; Lagacé J
    Biochim Biophys Acta; 2001 Nov; 1515(1):44-54. PubMed ID: 11597351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of beta-galactosidase synthesis in Escherichia coli by exogenous cyclic 3',5'-adenosine monophosphate].
    Kaliuzhnaia VM; Korobov VP
    Mikrobiologiia; 1991; 60(1):65-70. PubMed ID: 1654499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bistability and Nonmonotonic Induction of the lac Operon in the Natural Lactose Uptake System.
    Zander D; Samaga D; Straube R; Bettenbrock K
    Biophys J; 2017 May; 112(9):1984-1996. PubMed ID: 28494968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of catabolite repression and inducer exclusion on the bistable behavior of the lac operon.
    Santillán M; Mackey MC
    Biophys J; 2004 Mar; 86(3):1282-92. PubMed ID: 14990461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SsrA-mediated tagging and proteolysis of LacI and its role in the regulation of lac operon.
    Abo T; Inada T; Ogawa K; Aiba H
    EMBO J; 2000 Jul; 19(14):3762-9. PubMed ID: 10899129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene dosage as a regulatory factor for gene expression. I. In lambda plac5-infected cells.
    Luk KC; Mark KK
    J Gen Virol; 1982 Feb; 58(Pt 2):297-304. PubMed ID: 6278060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs.
    White DG; Maneewannakul K; von Hofe E; Zillman M; Eisenberg W; Field AK; Levy SB
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2699-704. PubMed ID: 9420041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of iso-propyl-thio-beta-D-galactoside concentration on the level of lac-operon induction in steady state Escherichia coli.
    Cho S; Scharpf S; Franko M; Vermeulen CW
    Biochem Biophys Res Commun; 1985 May; 128(3):1268-73. PubMed ID: 3924043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Ketoglutarate as a possible regulatory metabolite involved in cyclic AMP-dependent catabolite repression in Escherichia coli K12.
    Daniel J; Danchin A
    Biochimie; 1986 Mar; 68(2):303-10. PubMed ID: 3015255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of bistability in induction of the Escherichia coli lac operon.
    Dreisigmeyer DW; Stajic J; Nemenman I; Hlavacek WS; Wall ME
    IET Syst Biol; 2008 Sep; 2(5):293-303. PubMed ID: 19045824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific destruction of the second lac operator decreases repression of the lac operon in Escherichia coli fivefold.
    Eismann E; von Wilcken-Bergmann B; Müller-Hill B
    J Mol Biol; 1987 Jun; 195(4):949-52. PubMed ID: 3116268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP does not have an important role in carbon catabolite repression of the Escherichia coli lac operon.
    Narang A
    Nat Rev Microbiol; 2009 Mar; 7(3):250. PubMed ID: 19230236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.